Ciprofloxacin Hydrochloride Film-Coated Tablets
Ciprofloxacin Hydrochloride Film-Coated Tablets

Ciprofloxacin Hydrochloride Film-Coated Tablets

COMPOSITION
Each Ciprofloxacin Hydrochloride Film-Coated Tablets contains Ciprofloxacin Hydrochloride equivalent to Ciprofloxacin 500mg.
PHARMACOLOGICAL CLASSIFICATION
A 20.1.1 Broad and medium spectrum antibiotics PHARMACOLOGICAL ACTION
Mechanism of Action
Send Inquiry
APIS

 

Active Pharmaceutical Ingredient Latin Name Molecular Formula Defination Structural Formula
Ciprofloxacin Hydrochloride Film-Coated Tablets Ciprofloxacin Hydrochloride film Coated Tabulettae C17H21ClFN3O4 1-Cyclopropyl-6-fluor-4-oxo-7-piperazin-1-yl-1,4-dihydrochinolin-3-carbonsäurehydrochloridhydrat

product-151-65

 

product-344-238
API mixing
product-370-239
Filling
product-367-244
Vial sterilization

 

Details

 

Ciprofloxacin Hydrochloride Film-Coated Tablets:

Fluoroquinolones bring about their bactericidal action by inhibiting the bacterial DNA gyrase enzyme. DNA gyrase is responsible for continuous introduction of negative supercoils into DNA. This is an ATP dependent reaction that requires both strands of the DNA to be cut to permit passage of a segment of DNA through the break; the break is then resealed. Fluoroquinolones decrease the introduction of negative supercoils into DNA and cause rapid cessation of DNA synthesis by interfering with the propagation of DNA replication.

 

product-750-1120
product-750-1120
product-750-1120

 

Interactions

 

Concurrent administration of Ciprofloxacin Hydrochloride Film-Coated Tablets with theophylline may lead to elevated plasma concentrations of theophylline and prolongation of its elimination half-life. This may result in increased risk of theophylline-related adverse reactions. If concomitant use cannot be avoided, plasma levels of theophylline should be monitored and dosage adjustments made as appropriate.

 

Ciprofloxacin tablets should be administered 1-2 hours before, or at least 4 hours after taking iron preparations, antacids containing magnesium, aluminium, calcium or sucralfate as interference with absorption may occur. This restriction does not apply to antacids belonging to the class of H2 receptor blockers. Concomitant-administration of the nonsteroidal anti-inflammatory drug fenbufen with quinolones has been reported to increase the risk of central nervous system stimulation and convulsive seizures.

 

Monitoring of serum creatinine concentrations is advised in patients on concomitant cyclosporin therapy, as transient increases in serum creatinine concentrations have been observed. The simultaneous administration of ciprofloxacin and warfarin may intensify the action of warfarin.

 

In particular cases, concurrent administration of ciprofloxacin and glibenclamide can intensify the action of glibenclamide (hypoglycaemia).

 

Probenecid interferes with renal secretion of ciprofloxacin. Co-administration of probenecid and ciprofloxacin increases the ciprofloxacin serum concentrations.

 

Metoclopramide accelerates the absorption of ciprofloxacin, resulting in a shorter time to reach maximum plasma concentrations. No effect was seen on the bioavailability of ciprofloxacin.

 

Hot Tags: ciprofloxacin hydrochloride film-coated tablets, China ciprofloxacin hydrochloride film-coated tablets manufacturers, suppliers, factory, Penicillin V Potassium Tablets, vitamins injection, penicillin solid preparations, others powder injection, others solid preparations, Paracetamol Injection